154 related articles for article (PubMed ID: 31277053)
1. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial.
Giblett JP; Clarke S; Zhao T; McCormick LM; Braganza DM; Densem CG; O'Sullivan M; Adlam D; Clarke SC; Steele J; Fielding S; West NEJ; Villar SS; Hoole SP
Am Heart J; 2019 Sep; 215():41-51. PubMed ID: 31277053
[TBL] [Abstract][Full Text] [Related]
2. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: A randomized clinical trial with a 2-year follow-up.
Wang Q; Liang D; Wang F; Li W; Han Y; Zhang W; Xie Y; Xin W; Zhou B; Sun D; Cao F; Xiong L
Int J Cardiol; 2015 Sep; 194():28-35. PubMed ID: 26011261
[TBL] [Abstract][Full Text] [Related]
4. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial).
De Luca G; Iorio S; Venegoni L; Marino P
Am J Cardiol; 2012 Jan; 109(2):202-7. PubMed ID: 22000773
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
[TBL] [Abstract][Full Text] [Related]
7. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
[TBL] [Abstract][Full Text] [Related]
8. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
9. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
10. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
Kang MG; Kang Y; Jang HG; Kim K; Koh JS; Park JR; Hwang SJ; Hwang JY; Bae JS; Ahn JH; Jang JY; Park Y; Jeong YH; Kwak CH; Park HW
Coron Artery Dis; 2018 Nov; 29(7):589-596. PubMed ID: 29965838
[TBL] [Abstract][Full Text] [Related]
12. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
13. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
14. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
[TBL] [Abstract][Full Text] [Related]
15. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
[TBL] [Abstract][Full Text] [Related]
16. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
[TBL] [Abstract][Full Text] [Related]
17. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
18. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Aslanabadi N; Shirzadi HR; Asghari-Soufi H; Dousti S; Ghaffari S; Sohrabi B; Mashayekhi SO; Hamishehkar H; Entezari-Maleki T
Eur J Clin Pharmacol; 2015 Feb; 71(2):143-9. PubMed ID: 25475357
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled, double-blind trial to evaluate efficacy and safety of Shen-Yuan-Dan capsules, a traditional Chinese medicine, for treatment of peri-procedure myocardial injury following percutaneous coronary intervention.
Li X; Zhang Y; Liu HX; Shang JJ; Zhou Q; Li AY; Lai XL; Xing WL; Jia SH
Complement Ther Med; 2022 Oct; 69():102841. PubMed ID: 35643381
[TBL] [Abstract][Full Text] [Related]
20. Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes.
Basili S; Tanzilli G; Raparelli V; Calvieri C; Pignatelli P; Carnevale R; Dominici M; Placanica A; Arrivi A; Farcomeni A; Barillà F; Mangieri E; Violi F
Circ Cardiovasc Interv; 2014 Aug; 7(4):577-84. PubMed ID: 25074252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
